331 related articles for article (PubMed ID: 28041926)
1. Chronic Over-expression of Fibroblast Growth Factor 21 Increases Bile Acid Biosynthesis by Opposing FGF15/19 Action.
Zhang J; Gupte J; Gong Y; Weiszmann J; Zhang Y; Lee KJ; Richards WG; Li Y
EBioMedicine; 2017 Feb; 15():173-183. PubMed ID: 28041926
[TBL] [Abstract][Full Text] [Related]
2. Fibroblast Growth Factor 21 Response in a Preclinical Alcohol Model of Acute-on-Chronic Liver Injury.
Christidis G; Karatayli E; Hall RA; Weber SN; Reichert MC; Hohl M; Qiao S; Boehm U; Lütjohann D; Lammert F; Karatayli SC
Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360670
[TBL] [Abstract][Full Text] [Related]
3. Hepatocyte FRS2α is essential for the endocrine fibroblast growth factor to limit the amplitude of bile acid production induced by prandial activity.
Wang C; Yang C; Chang JY; You P; Li Y; Jin C; Luo Y; Li X; McKeehan WL; Wang F
Curr Mol Med; 2014; 14(6):703-711. PubMed ID: 25056539
[TBL] [Abstract][Full Text] [Related]
4. Interaction of glucocorticoids with FXR/FGF19/FGF21-mediated ileum-liver crosstalk.
Al-Aqil FA; Monte MJ; Peleteiro-Vigil A; Briz O; Rosales R; González R; Aranda CJ; Ocón B; Uriarte I; de Medina FS; Martinez-Augustín O; Avila MA; Marín JJG; Romero MR
Biochim Biophys Acta Mol Basis Dis; 2018 Sep; 1864(9 Pt B):2927-2937. PubMed ID: 29883717
[TBL] [Abstract][Full Text] [Related]
5. Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis.
Inagaki T; Choi M; Moschetta A; Peng L; Cummins CL; McDonald JG; Luo G; Jones SA; Goodwin B; Richardson JA; Gerard RD; Repa JJ; Mangelsdorf DJ; Kliewer SA
Cell Metab; 2005 Oct; 2(4):217-25. PubMed ID: 16213224
[TBL] [Abstract][Full Text] [Related]
6. Selective activation of FGFR4 by an FGF19 variant does not improve glucose metabolism in ob/ob mice.
Wu X; Ge H; Lemon B; Weiszmann J; Gupte J; Hawkins N; Li X; Tang J; Lindberg R; Li Y
Proc Natl Acad Sci U S A; 2009 Aug; 106(34):14379-84. PubMed ID: 19706524
[TBL] [Abstract][Full Text] [Related]
7. FGF15/FGFR4 integrates growth factor signaling with hepatic bile acid metabolism and insulin action.
Shin DJ; Osborne TF
J Biol Chem; 2009 Apr; 284(17):11110-20. PubMed ID: 19237543
[TBL] [Abstract][Full Text] [Related]
8. Mouse species-specific control of hepatocarcinogenesis and metabolism by FGF19/FGF15.
Zhou M; Luo J; Chen M; Yang H; Learned RM; DePaoli AM; Tian H; Ling L
J Hepatol; 2017 Jun; 66(6):1182-1192. PubMed ID: 28189755
[TBL] [Abstract][Full Text] [Related]
9. Differential specificity of endocrine FGF19 and FGF21 to FGFR1 and FGFR4 in complex with KLB.
Yang C; Jin C; Li X; Wang F; McKeehan WL; Luo Y
PLoS One; 2012; 7(3):e33870. PubMed ID: 22442730
[TBL] [Abstract][Full Text] [Related]
10. Tissue-specific expression of betaKlotho and fibroblast growth factor (FGF) receptor isoforms determines metabolic activity of FGF19 and FGF21.
Kurosu H; Choi M; Ogawa Y; Dickson AS; Goetz R; Eliseenkova AV; Mohammadi M; Rosenblatt KP; Kliewer SA; Kuro-O M
J Biol Chem; 2007 Sep; 282(37):26687-26695. PubMed ID: 17623664
[TBL] [Abstract][Full Text] [Related]
11. Monomeric/dimeric forms of Fgf15/FGF19 show differential activity in hepatocyte proliferation and metabolic function.
Williams CM; Harper Calderon J; E H; Jimenez Y; Barringer K; Carbonaro M; Molina-Portela MDP; Thurston G; Li Z; Daly C
FASEB J; 2021 Feb; 35(2):e21286. PubMed ID: 33484478
[TBL] [Abstract][Full Text] [Related]
12. FGF21 acts as a negative regulator of bile acid synthesis.
Chen MM; Hale C; Stanislaus S; Xu J; Véniant MM
J Endocrinol; 2018 May; 237(2):139-152. PubMed ID: 29615519
[TBL] [Abstract][Full Text] [Related]
13. FXR-induced secretion of FGF15/19 inhibits CYP27 expression in cholangiocytes through p38 kinase pathway.
Jung D; York JP; Wang L; Yang C; Zhang A; Francis HL; Webb P; McKeehan WL; Alpini G; Lesage GD; Moore DD; Xia X
Pflugers Arch; 2014 May; 466(5):1011-9. PubMed ID: 24068255
[TBL] [Abstract][Full Text] [Related]
14. Definition of a novel growth factor-dependent signal cascade for the suppression of bile acid biosynthesis.
Holt JA; Luo G; Billin AN; Bisi J; McNeill YY; Kozarsky KF; Donahee M; Wang DY; Mansfield TA; Kliewer SA; Goodwin B; Jones SA
Genes Dev; 2003 Jul; 17(13):1581-91. PubMed ID: 12815072
[TBL] [Abstract][Full Text] [Related]
15. Bile Acids as Hormones: The FXR-FGF15/19 Pathway.
Kliewer SA; Mangelsdorf DJ
Dig Dis; 2015; 33(3):327-31. PubMed ID: 26045265
[TBL] [Abstract][Full Text] [Related]
16. Diet1 is a regulator of fibroblast growth factor 15/19-dependent bile acid synthesis.
Reue K; Lee JM; Vergnes L
Dig Dis; 2015; 33(3):307-13. PubMed ID: 26045262
[TBL] [Abstract][Full Text] [Related]
17. TCF7L2 transcriptionally regulates Fgf15 to maintain bile acid and lipid homeostasis through gut-liver crosstalk.
Bhat N; Esteghamat F; Chaube BK; Gunawardhana K; Mani M; Thames C; Jain D; Ginsberg HN; Fernandes-Hernando C; Mani A
FASEB J; 2022 Mar; 36(3):e22185. PubMed ID: 35133032
[TBL] [Abstract][Full Text] [Related]
18. Impact of Inhibiting Ileal Apical versus Basolateral Bile Acid Transport on Cholesterol Metabolism and Atherosclerosis in Mice.
Dawson PA
Dig Dis; 2015; 33(3):382-7. PubMed ID: 26045273
[TBL] [Abstract][Full Text] [Related]
19. Cytoplasmic tyrosine phosphatase Shp2 coordinates hepatic regulation of bile acid and FGF15/19 signaling to repress bile acid synthesis.
Li S; Hsu DD; Li B; Luo X; Alderson N; Qiao L; Ma L; Zhu HH; He Z; Suino-Powell K; Ji K; Li J; Shao J; Xu HE; Li T; Feng GS
Cell Metab; 2014 Aug; 20(2):320-32. PubMed ID: 24981838
[TBL] [Abstract][Full Text] [Related]
20. Bile acids decrease hepatic paraoxonase 1 expression and plasma high-density lipoprotein levels via FXR-mediated signaling of FGFR4.
Gutierrez A; Ratliff EP; Andres AM; Huang X; McKeehan WL; Davis RA
Arterioscler Thromb Vasc Biol; 2006 Feb; 26(2):301-6. PubMed ID: 16284190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
